We are live on
!
Find out more
SCI
Stableford Capital II Portfolio holdings
AUM
$289M
1-Year Est. Return
20.84%
This Fund
S&P 500
This Quarter
Est. Return
+5.49%
1 Year Est. Return
+20.84%
3 Year Est. Return
+59.31%
5 Year Est. Return
+67.29%
10 Year Est. Return
–
AUM
$149M
AUM Growth
+$11M
(+8%)
Cap. Flow
+$4.3M
Cap. Flow
% of AUM
2.89%
Top 10 Holdings %
Top 10 Hldgs %
43.8%
Holding
117
New
7
Increased
64
Reduced
19
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.98M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$1.74M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.58M |
| 4 |
O'Reilly Automotive
ORLY
|
+$1.22M |
| 5 |
Vanguard Long-Term Corporate Bond ETF
VCLT
|
+$1.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.6M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.21M |
| 3 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$1.2M |
| 4 |
CVS Health
CVS
|
+$1.05M |
| 5 |
Pfizer
PFE
|
+$992K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.42% |
| 2 | Communication Services | 9.34% |
| 3 | Healthcare | 7.56% |
| 4 | Energy | 7.24% |
| 5 | Consumer Staples | 7.1% |
Similar funds
LK
PSA
WCA
GIM
PIA
WPWM
BWAM
LWP
Stableford Capital II's Q4 2017 Portfolio in Review
As of Q4 2017, Stableford Capital II held 117 positions worth $149M, up 8% from $138M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Stableford Capital II's Q4 2017 filing shows 7 new, 64 increased, 19 reduced and 16 closed positions. Its largest new stake was iShares Core S&P Small-Cap ETF: 23,102 shares worth $1.77M. The largest sale was Allergan plc, an estimated $1.6M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Communication Services and Healthcare.
- Stableford Capital II's largest Q4 2017 buy was iShares Core S&P Small-Cap ETF: 23,102 shares worth $1.77M.
- Stableford Capital II added most to iShares Core S&P 500 ETF in Q4 2017, an estimated $1.98M increase.
- Stableford Capital II's biggest Q4 2017 reduction was Pfizer, cutting an estimated $992K.
- Stableford Capital II fully exited Allergan plc in Q4 2017, selling an estimated $1.6M.
- Stableford Capital II's ten largest holdings make up 44% of its $149M portfolio in Q4 2017.
- Stableford Capital II opened 7 new positions and closed 16 in Q4 2017.
- Stableford Capital II's portfolio value rose 8% quarter-over-quarter to $149M.
Based on Stableford Capital II's 13F filing for Q4 2017, filed 10 Feb 2021.